Moreover, in hepatitis C, increased CD2-associated proteins have been demonstrated to influence lipid metabolism through the IRS1-Akt-AMPK-HSL pathway, causing deactivation of hormone-sensitive lipase and consequent augmentation of lipid droplet accumulation, ultimately promoting steatosis (51). The gene discussed is AKT1; the disease is steatosis.